Atlas Trials

A Study to Evaluate the Efficacy and Safety of Therapeutic Hepatitis B Vaccine

Clinical trial NCT04289987 · COMPLETED

Trial details

NCT number
NCT04289987
Sponsor
Aribio Lab Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatitis B, Chronic
Start date
2020-02-19
Primary completion
2023-12-04
Enrollment
134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.